Open Access<p>Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer</p>
Author(s) -
Tatsuya Yoshida,
Takuya Miura,
Tomoh Matsumiya,
Hidemi Yoshida,
Hajime Morohashi,
Yoshiyuki Sakamoto,
Akira Kurose,
Tadaatsu Imaizumi,
Kenichi Hakamada
Publication year - 2020
Publication title -
clinical and experimental gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.113
H-Index - 30
ISSN - 1178-7023
DOI - 10.2147/ceg.s252157
Subject(s) - medicine , colorectal cancer , chemokine , ccl5 , oncology , immunohistochemistry , cancer research , receptor , cancer , immunology , t cell , immune system , il 2 receptor
Colorectal cancer (CRC) often recurs after curative resection. Identification of major risk factors for CRC recurrence is important for effective prevention and treatment. In this study, we examined the potential relationship between CRC and TLR3 as this remains unclear.